Our western blot assay showed that TP53INP2-overexpressed ccRCC cells come in an increasing levels of epithelial marker E-cadherin whereas resulted in a decrease in mesenchymal marker expression (Ncadherin and vimentin) (Figures 7(k)–7(n)). The gene discussed is CDH1; the disease is nonpapillary renal cell carcinoma.